MiR-200b-3p is upregulated in the placental tissues from patients with preeclampsia and promotes the development of preeclampsia via targeting profilin 2

References

• Fox R, Kitt J, Leeson P, et al. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019;8:1625.
   Web of Science ®Google Scholar
• Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:1690–1702.
   PubMed Web of Science ®Google Scholar
• Gatford KL, Andraweera PH, Roberts CT, et al. Animal models of preeclampsia: causes, consequences, and interventions. Hypertension. 2020;75:1363–1381.
   PubMed Web of Science ®Google Scholar
• Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016;27:71–78.
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.
   PubMed Web of Science ®Google Scholar
• Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019;134-135:1–10.
   PubMed Web of Science ®Google Scholar
• Benmoussa A, Provost P. Milk microRNAs in health and disease. Compr Rev Food Sci Food Saf. 2019;18(3):703–722.
   PubMed Web of Science ®Google Scholar
• Bounds KR, Chiasson VL, Pan LJ, et al. MicroRNAs: new players in the pathobiology of preeclampsia. Front Cardiovasc Med. 2017;4:60.
   PubMed Web of Science ®Google Scholar
• Skalis G, Katsi V, Miliou A, et al. MicroRNAs in preeclampsia. Microrna. 2019;8(1):28–35.
   PubMedGoogle Scholar
• Lykoudi A, Kolialexi A, Lambrou GI, et al. Dysregulated placental microRNAs in early and late onset preeclampsia. Placenta. 2018;61:24–32.
   PubMed Web of Science ®Google Scholar
• Niu Z-R, Han T, Sun X-L, et al. MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1. Am J Obstet Gynecol. 2018;218:249.e1–.e12.
   PubMed Web of Science ®Google Scholar
• Song H, Wang X, Li JC, et al. MiR-655-3p inhibits growth and invasiveness of trophoblasts via targeting PBX3 and thus deteriorates preeclampsia. Eur Rev Med Pharmacol Sci. 2020;24:10346–10351.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Zhu F, Ding Y. Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies. Exp Ther Med. 2019;18:826–832.
   PubMed Web of Science ®Google Scholar
• Lv Y, Lu C, Ji X, et al. Roles of microRNAs in preeclampsia. J Cell Physiol. 2019;234:1052–1061.
   PubMed Web of Science ®Google Scholar
• Awamleh Z, Gloor GB, Han VK. Placental microRNAs in pregnancies with early onset intrauterine growth restriction and preeclampsia: potential impact on gene expression and pathophysiology. BMC Med Genomics. 2019;12:1–10.
   PubMed Web of Science ®Google Scholar
• Hornakova A, Kolkova Z, Holubekova V, et al. Diagnostic potential of MicroRNAs as biomarkers in the detection of preeclampsia. Genet Test Mol Biomarkers. 2020;24:321–327.
   PubMed Web of Science ®Google Scholar
• Xie X, Kong B, Duan T. Obstetrics and Gynecology. 9th ed. China: People’s Medical Publishing House; 2018.
   Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):1–21.
   Web of Science ®Google Scholar
• Enright A, John B, Gaul U, et al. MicroRNA targets in Drosophila. Genome Biol. 2003;4:1–27.
   Web of Science ®Google Scholar
• Lewis BP, Shih I-H, Jones-Rhoades MW, et al. Prediction of mammalian microRNA targets. Cell. 2003;115:787–798.
   PubMed Web of Science ®Google Scholar
• Smyth GK Limma: linear models for microarray data. In: Bioinformatics and computational biology solutions using R and bioconductor. NewYork (USA): Springer; 2005. p. 397–420.
   Google Scholar
• Phipps E, Prasanna D, Brima W, et al. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clin J Am Soc Nephrol. 2016;11:1102–1113.
   PubMed Web of Science ®Google Scholar
• Staud F, Karahoda R. Trophoblast: the central unit of fetal growth, protection and programming. Int J Biochem Cell Biol. 2018;105:35–40.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhou X, Han T-L, et al. Decreased IL-33 production contributes to trophoblast cell dysfunction in pregnancies with preeclampsia. Mediators Inflamm. 2018;2018:9787239.
   PubMed Web of Science ®Google Scholar
• Mao Y, Hou B, Shan L, et al. Aberrantly up-regulated miR-142-3p inhibited the proliferation and invasion of trophoblast cells by regulating FOXM1. Placenta. 2021;104:253–260.
   PubMed Web of Science ®Google Scholar
• Liu E, Zhou Y, Li J, et al. MicroRNA‑491‑5p inhibits trophoblast cell migration and invasion through targeting matrix metalloproteinase‑9 in preeclampsia. Mol Med Rep. 2020;22:5033–5040.
   PubMed Web of Science ®Google Scholar
• Tao J, Xia LZ, Liang L, et al. MiR-124-3p promotes trophoblast cell HTR-8/SVneo pyroptosis by targeting placental growth factor. Placenta. 2020;101:176–184.
   PubMed Web of Science ®Google Scholar
• Cao G, Cui R, Liu C, et al. MicroRNA regulation of transthyretin in trophoblast biofunction and preeclampsia. Arch Biochem Biophys. 2019;676:108129.
   PubMed Web of Science ®Google Scholar
• Zhou WJ, Wang HY, Zhang J, et al. NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma. Aging (Albany NY). 2020;12:22759–22775.
   PubMedGoogle Scholar
• Liu K, Zhang W, Tan J, et al. MiR-200b-3p functions as an oncogene by targeting ABCA1 in lung adenocarcinoma. Technol Cancer Res Treat. 2019;18:1533033819892590.
   Web of Science ®Google Scholar
• Chen L, Wang X, Zhu Y, et al. miR‑200b‑3p inhibits proliferation and induces apoptosis in colorectal cancer by targeting Wnt1. Mol Med Rep. 2018;18:2571–2580.
   PubMed Web of Science ®Google Scholar
• Liu H, Yu J, Yuan W, et al. Microarray analysis of preterm preeclampsia. Cell Mol Biol. 2020;66:59–64.
   Web of Science ®Google Scholar
• Zhang H, Yang W, Yan J, et al. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer. Int J Oncol. 2018;53:1118–1128.
   PubMed Web of Science ®Google Scholar
• Zhou K, Chen J, Wu J, et al. Profilin 2 promotes proliferation and metastasis of head and neck cancer cells by regulating PI3K/AKT/β-catenin signaling pathway. Oncol Res. 2019;27:1079.
   PubMed Web of Science ®Google Scholar
• Ling Y, Cao Q, Liu Y, et al. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells. Breast Cancer. 2021;28:368–378.
   PubMed Web of Science ®Google Scholar
• Miao R, Dong X, Gong J, et al. Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension. Thromb Res. 2021;198:122–131.
   PubMed Web of Science ®Google Scholar
• Fisher SJ, McMaster M, Roberts JM The placenta in normal pregnancy and preeclampsia. In: Chesley’s hypertensive disorders in pregnancy. Amsterdam (Netherlands): Elsevier; 2015. p. 81–112.
   Google Scholar
• Turner RJ, Bloemenkamp KW, Bruijn JA, et al. Loss of thrombomodulin in placental dysfunction in preeclampsia. Arterioscler Thromb Vasc Biol. 2016;36:728–735.
   PubMed Web of Science ®Google Scholar
• Adu-Gyamfi EA, Czika A, Gorleku PN, et al. The involvement of cell adhesion molecules, tight junctions, and gap junctions in human placentation. Reprod Sci. 2021;28:305–320.
   PubMed Web of Science ®Google Scholar
• Haram K, Mortensen JH, Myking O, et al. The role of oxidative stress, adhesion molecules and antioxidants in preeclampsia. Curr Hypertens Rev. 2019;15:105–112.
   PubMed Web of Science ®Google Scholar